Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson'...

Kenvue Inc. (KVUE) has a valuation score of 82/100 (strong), profitability score of 65/100 (moderate), financial health score of 61/100 (moderate), Piotroski F-Score of 6/9, Altman Z-Score of 1.59 (distressed), revenue growth of +0.4% YoY.

Neutral

Analyst Consensus

Hold

Wall Street consensus estimates — not a PMP forecast · Updated Aug 31, 2026

Analyst Recommendations20 analysts · 2026-08-01
2
4
14
Strong Buy 2Buy 4Hold 14Sell 0Strong Sell 0

Recent Market Moves

See all KVUE moves →
DateSessionPriceMoveZ-Score
Aug 6Regular$19.03-3.25%-2.17